5-Bromoimidazo[1,2-a]pyridine

Catalog No.: 
ACXMFJ396
CAS No.: 
69214-09-1
Molecular Formula: 
C7H5BrN2
Molecular Weight: 
197.04
5-Bromoimidazo[1,2-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g96%$51.00In stockIn stock
25g96%$115.00In stockIn stock
100g96%$459.00In stockIn stock
500g96%$2088.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromoimidazo[1,2-a]pyridine
IUPAC Name5-bromoimidazo[1,2-a]pyridine
MDL No.MFCD08275698
Molecular FormulaC7H5BrN2
Molecular Weight197.04
SMILESBrC1=CC=CC2=NC=CN12
InChI KeyCCOFGVWHMYYDBG-UHFFFAOYSA-N
SynonymPS-4741 | SY027670 | CS-W003496 | MFCD08275698 | AM20061851 | 5-Bromo-imidazo[1,2-a]pyridine | 5-Bromoimidazo[1,2-a]pyridine | BBL103358 | EN300-90102 | PB32607 | 5-Bromoimidazo[1,2-a]pyridine HBr | 5-Bromoimidazo[1,2-a]pyridine, 96% | STL557168 | AC-2582
CAS No.69214-09-1
PubChem CID13037241

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXMFJ396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXMFJ396 route compound structure diagram
    ACXMFJ39669214-09-1In Stock
  4. Then
  5. ACXMFJ396 route product structure diagram
    ACXMFJ39669214-09-1In Stock
Inquiry

2. ACXMFJ396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXMFJ396 route product structure diagram
    ACXMFJ39669214-09-1In Stock
Inquiry

3. ACXMFJ396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXMFJ396 route product structure diagram
    ACXMFJ39669214-09-1In Stock
Inquiry

Comments (0)